Abstract：Objective To investigate the clinical effect of Shenqi Fuzheng Injection combined with TP regimen in the treatment of ovarian cancer.Methods From February 2013 to January 2016,clinical data of 50 patients with ovarian cancer treated in our hospital were retrospectively analyzed and patients were divided into the observation group(n=25) and the control group(n=25)according to clinical data of patients.Both groups were treated with Taxol and Platinum(TP regimen).On the basis,the observation group was treated with Shenqi Fuzheng Injection,intravenous drip of 250 ml Shenqi Fuzheng Injection,once a time,and 3 weeks was a cycle.The efficacy of treatment,quality of life(KPS)and the incidence of adverse reactions were compared between two groups.Results There was no significant difference in the total effective rate and disease control rate between the two groups(P＞0.05).The improvement rate of KPS score in the observation group was 96.0%while in the control group was 72.0%,and there was a statistical difference between two groups(P＜0.05).The incidence rate of leukopenia,hair loss,bone marrow suppression,vomiting and nausea,gastrointestinal reactions and other adverse reactions in the observation group were lower than those in the control group,the differences were statistically significant(P＜0.05).Conclusion The clinical effect of Shenqi Fuzheng Injection combined with TP regimen is significantin the treatment of ovarian cancer.It can significantly improve the quality of life of patients,reduce the adverse reactions caused by chemotherapy,and improve patients′tolerance to drugs,which has positive effect on the prognosis of patients,it is worthy of clinical prumotion an application.
京公网安备 11010502046607号